KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Payables (2016 - 2026)

CareDx's Payables history spans 14 years, with the latest figure at $9.1 million for Q1 2026.

  • On a quarterly basis, Payables rose 12.31% to $9.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.1 million, a 12.31% increase, with the full-year FY2025 number at $10.0 million, up 29.95% from a year prior.
  • Payables hit $9.1 million in Q1 2026 for CareDx, down from $10.0 million in the prior quarter.
  • Over the last five years, Payables for CDNA hit a ceiling of $16.9 million in Q2 2022 and a floor of $5.9 million in Q2 2024.
  • Historically, Payables has averaged $10.1 million across 5 years, with a median of $9.9 million in 2022.
  • Biggest five-year swings in Payables: crashed 41.51% in 2023 and later surged 85.88% in 2025.
  • Tracing CDNA's Payables over 5 years: stood at $9.9 million in 2022, then rose by 29.47% to $12.9 million in 2023, then tumbled by 40.29% to $7.7 million in 2024, then rose by 29.95% to $10.0 million in 2025, then dropped by 9.23% to $9.1 million in 2026.
  • Business Quant data shows Payables for CDNA at $9.1 million in Q1 2026, $10.0 million in Q4 2025, and $11.6 million in Q3 2025.